Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up

By  

Current Pharmaceutical Design, Vol. 17, Iss. 26, 2011-09 ,pp. : 2793-2802

Bentham Science Publishers

Access to resources Recommend Favorite

The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells

By Brooks Tracy   O’Loughlin Kieran   Minderman Hans   Bundy Brian   Ford Laurie   Vredenburg Michael   Bernacki Ralph   Priebe Waldemar   Baer Maria  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer

By Xu H-W   Xu L   Hao J-H   Qin C-Y   Liu H  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 34-42

Field House Publishing

Access to resources Recommend Favorite

siRNA-Mediated Knock-Down of P-Glycoprotein Expression Reveals Distinct Cellular Disposition of Anticancer Tyrosine Kinases Inhibitors

By  

Drug Metabolism Letters, Vol. 4, Iss. 2, 2010-04 ,pp. : 114-119

Bentham Science Publishers

Access to resources Recommend Favorite

CHLORPYRIFOS OXON INTERACTS WITH THE MAMMALIAN MULTIDRUG RESISTANCE PROTEIN, P-GLYCOPROTEIN

By Lanning Christine L.   Fine Robert L.   Sachs Clifford W.   Rao U. S.   Corcoran James J.  

Journal of Toxicology and Environmental Health, Vol. 47, Iss. 4, 1996-03 ,pp. : 395-407

Taylor & Francis Ltd

Access to resources Recommend Favorite